Faculty Researchers
The Institute is encouraging scientists in developing new programs of research with special emphasis on neurodegeneration and age-related diseases.
Paula Grammas, Ph.D.
Dr. Grammas serves as the GIA's executive director and leads the Grammas Research Group, a team of postdoctoral research associates and students investigating the role that endothelial cells play in vascular-mediated neuronal cell death in Alzheimer's disease. With funding from the National Institutes of Health (NIH), Dr. Grammas has received national recognition for her research in Alzheimer's disease. Dr. Grammas is recruiting a Neurodegenerative Research Team to advance the GIA Alzheimer's disease research program to national prominence.
Andrew Dentino, M.D.
Dr. Dentino, a geriatrician, is a professor in the departments of Family and Community Medicine and Internal Medicine in the TTUHSC School of Medicine. He serves as Director of Geriatrics and Clinical Care in the Garrison Institute on Aging.
Inna Kruman, Ph.D.
Dr. Kruman is an Associate Professor and Faculty Researcher in the Department of Neuropsychiatry and at the Garrison Institute on Aging. Her research aims to explore the protection of genomic integrity as a major challenge for living cells which are continuously exposed to endogenous and environmental DNA-damaging agents.
Dr. Mark Lyte, Ph.D., MS, MT (ASCP)
Dr. Lyte serves as the Director of Translational Research, spearheading efforts to join basic scientists and clinicians in joint research projects. His research, in the emerging field of microbial endocrinology, examines the interface between microorganisms and the neuroendocrine system in both health and disease. This NIH-funded research explores new approaches to neurological pathology.
Sid O'Bryant, Ph.D.
Dr. O'Bryant leads the O'Bryant Research Group which oversees the Cochran County Aging Study. The long-term project is investigating cognitive decline and dementia syndromes in a rural setting.
Xingjia Wang, Ph.D.
Dr. Wang serves as the Director of Trainee Development and leads the Wang Research Group. He is currently investigating the role of cyclooxygenase-2 in testosterone biosynthesis in male aging as well as the role of testosterone in Alzheimer's disease, with funding from the NIH.